Pharmacytimes: Condition Center: HIV HIV en-us Fri, 24 Feb 2017 04:59:15 UTC Fri, 24 Feb 2017 04:59:15 UTC HIV PrEP: Increasing Willingness and Intent to Engage A team of researchers from the City University of New York found fewer than 1 in 10 suitable PrEP candidates are currently taking PrEP, in a new article published in <em>Journal of Acquired Immune Deficiency Syndrome</em>. 9:48 AM, Mon February 20, 2017 CROI 2017: Daily Oral PrEP Effective Even in Presence of Bacterial Vaginosis Women with abnormal vaginal microbiota showed no difference in efficacy of daily oral PrEP compared to women with normal vaginal microbiota, according to data presented at the annual Conference on Retroviruses and Opportunistic Infections in Seattle.&nbsp; 12:46 PM, Thu February 16, 2017 CROI 2017: Positive Results Reported for Two-drug HIV Regimen The program&nbsp;comprises 2&nbsp;studies with over 1000 patients who previously achieved viral suppression on a 3- or 4-drug antiretroviral regimen.&nbsp; 9:34 PM, Wed February 15, 2017 Effects of Recreational Drug Use in Patients Taking HAART Recreational drug use has been established as a risk factor for HIV acquisition, and many patients will find lifestyle modification&mdash;eschewing recreational drug use&mdash;difficult.&nbsp; 9:06 AM, Tue February 7, 2017 CDC: Improved HIV Care Needed for African Americans February 7 marks National Black HIV/AIDS Awareness Day, which promotes awareness of HIV and AIDS and the disparity in care between African Americans in the United States compared to individuals of different races.&nbsp;<br /> &nbsp; 9:33 AM, Mon February 6, 2017 Is HIV A Risk Factor for Diabetes? Adults who have HIV are more likely to develop diabetes than the general population, a study published in <em>BMJ Open Diabetes Research &amp; Care</em> estimates.&nbsp; 8:30 AM, Thu February 2, 2017 Misconceptions About Nicotine Among People Living with HIV Researchers at Johns Hopkins University investigated knowledge of smoking and nicotine among HIV-positive smokers in a study published online in <em>Addictive Behaviors</em>.&nbsp; 11:43 AM, Thu January 26, 2017 HIV Neutralizing Antibody Showing Promise in Clinical Trial 10-1074 was well-tolerated, demonstrated favorable pharmacokinetic properties, and had high antiviral activity among patients with HIV, a recent study found.&nbsp; 12:13 PM, Tue January 24, 2017 Study Notes Missed Opportunity for HIV Detection A new study, published in <em>Psychiatric Services,</em> reveals a missed opportunity for early HIV detection and treatment.&nbsp; 9:44 AM, Tue January 24, 2017 ART in HIV: Start Today In HIV treatment, national and global guidelines recommend initiating antiretroviral therapy (ART) in all patients, regardless of CD4 count.&nbsp; 2:29 PM, Tue January 10, 2017 Statin Use in HIV: Check Vitamin D Levels A study published in a recent issue of the <em>Journal of Acquired Immune Deficiency Syndromes</em> demonstrates that low baseline vitamin D deficiency may decrease the effectiveness of rosuvastatin in adults with HIV.<br /> &nbsp; 2:08 PM, Mon January 9, 2017 Counsel PrEP and ART Strategies in HIV-Serodiscordant Couples Experts agree that integrated antiretroviral therapy (ART) for HIV-positive partners and time-limited pre-exposure prophylaxis (PrEP) for negative partners almost eliminates HIV transmission.&nbsp; 11:43 AM, Thu December 29, 2016 Studies in Virology Every Pharmacist Should Know Over the years, a number of landmark clinical studies in virology have been published, shaping how we treat the disease today. 10:35 PM, Tue December 27, 2016 5 Studies That Shaped HIV Treatment That Every Pharmacist Should Know Over the years, a number of landmark clinical studies in the field of virology have been published, shaping how we treat many infectious diseases today 9:43 PM, Tue December 27, 2016 The HIV Epidemic: Is Increased Access to Syringe Services the Answer? Syringe services programs (SSPs) aim to reduce the spread of HIV among people who inject drugs (PWID), as use of shared needles puts them at high risk of contracting or transmitting the infection.&nbsp; 6:00 AM, Wed December 21, 2016 Awaiting a Long-Acting PrEP Dosage Form An antiretroviral vaginal ring is being investigated to quell the spread of HIV. 2:26 AM, Wed December 21, 2016 Opportunistic Infections: Better Have a Pharmacist Onboard Approximately 1.2 million individuals live with HIV/AIDS in the United States. This population is at an increased risk of opportunistic infections (OIs), an area where pharmacists have significant potential to make meaningful interventions.&nbsp; 10:56 AM, Mon December 19, 2016 A Shift In Thinking on When to Initiate Antiretroviral Therapy The recommended time to begin antiretroviral therapy (called the ART-start threshold) has changed since ART first arrived in the mid 90s. Now, clinicians are able to prescribe ART more liberally because of its improved adverse event profile and wider array of available drugs. 12:49 PM, Thu December 15, 2016 These Treatments Improve PHT in Patients With HIV and HCV Patients who have human immunodeficiency virus (HIV) infection are at elevated risk for HCV. 3:04 PM, Tue December 13, 2016 WATCH: WHO Guide to Testing Options for HIV In this week&#39;s &quot;Around the Web,&quot; <em>Pharmacy Times</em> presents a video that was recently posted by the World Health Organization, which discusses self-testing options for HIV. 11:10 AM, Fri December 2, 2016